A decision is expected soon in the case challenging the FDA's approval more than 20 years ago of the abortion drug mifepristone, which a growing number of patients use to terminate pregnancies.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
